BLCO

BLCO

USD

Bausch + Lomb Corporation Common Shares

$15.550+0.080 (0.517%)

Precio en Tiempo Real

Healthcare
Medical Instruments & Supplies
Canadá

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$15.470

Máximo

$15.554

Mínimo

$15.300

Volumen

0.81M

Fundamentos de la Empresa

Capitalización de Mercado

5.5B

Industria

Medical Instruments & Supplies

País

Canada

Estadísticas de Negociación

Volumen Promedio

0.52M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $10.45Actual $15.550Máximo $20.712

Noticias Relacionadas

BusinessWire

Bausch + Lomb to Hold Investor Day on Nov. 13

Bausch + Lomb Corporation (NYSE/TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, will hold an investor day on Thursday, Nov. 13, 2025, at the New York Stock

Ver más
Bausch + Lomb to Hold Investor Day on Nov. 13
Analyst Upgrades

Barclays Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $17

Barclays analyst Matt Miksic maintains Bausch & Lomb with a Equal-Weight and raises the price target from $16 to $17.

Ver más
Barclays Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $17
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Bausch & Lomb, Raises Price Target to $17

HC Wainwright & Co. analyst Yi Chen maintains Bausch & Lomb with a Buy and raises the price target from $16 to $17.

Ver más
HC Wainwright & Co. Maintains Buy on Bausch & Lomb, Raises Price Target to $17
Analyst Upgrades

JP Morgan Maintains Neutral on Bausch & Lomb, Raises Price Target to $16

JP Morgan analyst Robbie Marcus maintains Bausch & Lomb with a Neutral and raises the price target from $13 to $16.

Ver más
JP Morgan Maintains Neutral on Bausch & Lomb, Raises Price Target to $16
Analyst Upgrades

Evercore ISI Group Maintains Outperform on Bausch & Lomb, Raises Price Target to $18

Evercore ISI Group analyst Vijay Kumar maintains Bausch & Lomb with a Outperform and raises the price target from $17 to $18.

Ver más
Evercore ISI Group Maintains Outperform on Bausch & Lomb, Raises Price Target to $18
Analyst Upgrades

Wells Fargo Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $16

Wells Fargo analyst Larry Biegelsen maintains Bausch & Lomb with a Equal-Weight and raises the price target from $15 to $16.

Analyst Upgrades

Raymond James Reiterates Outperform on Bausch & Lomb, Raises Price Target to $19

Raymond James analyst Gary Nachman reiterates Bausch & Lomb with a Outperform and raises the price target from $18 to $19.

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.